论文部分内容阅读
目的 :对比分析在高危孕妇剖宫产术术后出血的临床预防中欣母沛和米索前列醇的应用效果。方法 :选取2014年1月至2015年6月在我院接诊和分娩的高危孕妇130例作为研究对象,按照随机分组原则将孕妇分为对照组和观察组分别65例,对照组产妇采用米索前列醇进行产后出血的预防,观察组产妇则采用欣母沛进行产后出血的预防,对比两组产妇的产后出血预防效果。结果 :观察组产妇的产后出血量以及产后出血人数均明显低于对照组,差异显著具有统计意义(P<0.05),两组产妇分娩过程中的不良反应事件发生率无统计学差异(P>0.05)。结论 :在高危孕妇剖宫产术术后出血的预防中欣母沛应用效果更佳,降低产后出血率的同时降低产后出血率,值得在临床上推广应用。
OBJECTIVE: To compare and analyze the clinical effect of Xin-mian-pei and misoprostol in the clinical prevention of post-cesarean section bleeding in high-risk pregnant women. Methods: From January 2014 to June 2015, 130 high-risk pregnant women in our hospital were selected as study subjects. According to the principle of random grouping, pregnant women were divided into control group and observation group, 65 cases in each group. Control group, Supramolecular prophylaxis for postpartum hemorrhage, the observation group of maternal use Xin Yan Pei for the prevention of postpartum hemorrhage, compared with the two groups of maternal postpartum hemorrhage prevention effect. Results: The postpartum hemorrhage and the number of postpartum hemorrhage in the observation group were significantly lower than those in the control group (P <0.05). There was no significant difference in the incidence of adverse reactions among the two groups during delivery (P> 0.05). Conclusion: In the prevention of bleeding after cesarean section in high-risk pregnant women, Yan-Pei-Pei’s application is more effective, reducing the rate of postpartum hemorrhage and reducing the rate of postpartum hemorrhage, which is worth popularizing and applying clinically.